BioCentury
ARTICLE | Company News

Endo, Jubilant Life Sciences deal

February 20, 2012 8:00 AM UTC

Jubilant's Jubilant Biosys Ltd. subsidiary received an undisclosed milestone payment after Endo selected a drug candidate targeting cancer for full development under the partners' 2009 deal. The undis...